Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Pain Med. 2018 Mar 1;19(3):511–523. doi: 10.1093/pm/pnx015

Table 2.

Drug Overdose Decedents’ Toxicology Reports and Substance Use History – Rhode Island, January 2012 – March 2014 (N=536)

Total
N (%)
Drug Overdose Deaths
N (%)
Chi-Square Test (p-value)

Illicit-Fentanyl (N=69) Other-Drug (N=467)
Toxicological Reports of Substances Present in Decedent’s Body
 Illicit substances
  Cocaine (P) 169 (31.5) 27 (39.1) 142 (30.4) 0.146
  Heroin* 162 (30.2) 13 (18.8) 149 (31.9) 0.000
  6MAM (C) 48 (9.0) 3 (4.4) 45 (9.6) 0.151
  Non-fentanyl-related illicit substance** 336 (62.7) 40 (58.0) 296 (63.4) 0.386
 Fentanyl-related substances
  Acetyl fentanyl (C) 15 (2.8) 14 (20.3) 1 (0.2) <0.000
  ANPP (C) 10 (1.9) 9 (13.0) 1 (0.2) <0.000
  Fentanyl (C) 42 (7.8) 35 (50.7) 7 (1.5) <0.000
  Fentanyl (P) 79 (14.7) 68 (98.6) 11 (2.4) <0.000
 Opiates (P) 269 (37.7) 26 (37.7) 243 (52.0) 0.026
 Pharmaceutical substances
  Acetaminophen (P) 28 (5.2) 0 (0.0) 28 (6.0) 0.38***
  Benzodiazepines (C) 204 (38.1) 24 (34.8) 180 (38.5) 0.548
  Carisoprodol (P) 14 (2.6) 0 (0.0) 14 (3.0) 0.234***
  Codeine (C) 75 (14.0) 3 (4.4) 72 (15.4) 0.013
  Methadone (P) 71 (13.3) 3 (4.4) 68 (14.6) 0.020
  Morphine (C) 188 (35.1) 16 (23.2) 172 (36.8) 0.027
  Oxycodone (P) 81 (15.1) 2 (2.9) 79 (16.9) 0.002
  Tricyclic antidepressants (P) 66 (12.3) 4 (5.8) 62 (13.3) 0.078
  Zolpidem (P) 16 (3.0) 2 (2.9) 14 (3.0) 0.964
Reported Recent Substance Use
 Alcohol 259 (48.3) 26 (37.7) 233 (49.9) 0.058
 Tobacco 239 (44.6) 36 (52.2) 203 (43.5) 0.175
 Illicit drug use
  Any type 256 (47.8) 43 (62.3) 213 (45.6) 0.002
  Heroin 166 (31.0) 34 (49.3) 132 (28.3) 0.000
Reported Prior Drug Overdose 73 (13.6) 9 (13.0) 64 (13.7) 1.000***
Reported Past Drug Addiction Treatment 97 (18.1) 16 (23.2) 81 (17.3) 0.411***
Filled ≥1 Opioid Prescriptionz (within 90 days of death)
  No 350 (65.3) 45 (65.2) 305 (65.3) 0.988
  Yes 186 (34.7) 24 (34.8) 162 (34.7)

Notes: Percentages refer to the proportion of decedents represented within illicit-fentanyl and other-drug overdose deaths (i.e., column percentages). Information on recent substance use, prior overdose and past drug treatment or rehabilitation was obtained by reviewing each decedent’s medical examiner chart, which was based on 3rd party reports (e.g., family members, friends, medical records). Bold indicates that differences between illicit-fentanyl and other-drug deaths are statistically significant.

*

Toxicological heroin evidence was defined as the presence of morphine and at least one of the following requirements: codeine or 6MAM identified in toxicology, presence of track marks in decedent’s body, or presence of intravenous drug paraphernalia on the death scene.

**

Includes the following illicit substances: amphetamine, cannabinoids, cocaine, methamphetamine, 6MAM and heroin; and opiates. Excludes other licit prescription substances presented on the table (e.g., codeine, morphine) which may or may not have been consumed by decedents for legitimate medical purposes.

***

Fisher’s Exact Test (p-value) is presented due to small expected cell counts.

(P) = Preliminary toxicology results (i.e., ELISA)

(C) = Confirmatory toxicology results

ANPP = 4-anilino-N-phenethyl-4-piperidine

6MAM = 6-Monoacetylmorphine